• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa


News provided by

Fosun Pharma

Apr 29, 2020, 12:50 ET

Share this article

Share this article


SHANGHAI, April 29, 2020 /PRNewswire/ -- In order to support African medical institutions in their response to the COVID-19 pandemic, Fosun Pharma (Stock Code: 600196.SH, 02196.HK), partnering with Shanghai Fosun Foundation, Fosun Medical and Tridem Pharma, People's Daily Health platform and the Health Times, held an "eCME on COVID-19 Case Management" at 19:00 Beijing time, 28 April. Professor Lu Hongzhou, CPC Committee Secretary of Shanghai Public Health Clinical Centre and an infectious disease expert, together with other 3 renowned national and international experts, interacted online with health officials and healthcare professionals from over 10 African countries; sharing their experiences in fighting COVID-19 and introducing updates on clinical research. This webinar was focused on the management of COVID-19 in African medical facilities with limited resources.

Since the COVID-19 outbreak, Fosun Pharma, an international pharmaceutical company, has taken an active part in the battle. It has joined hands with many organizations to aid the global fight against COVID-19. This workshop was Fosun's third in a series of international webinars which began with the 6 April webinar of Chinese, European and American experts, and then the eCME of global pediatric specialists held in cooperation with Children's Hospital of Fudan University on 16 April. Mr. Wu Yifang, President and CEO of Fosun Pharma, said, "Fosun Pharma has been operating in Africa for over decade and has nearly 1,000 employees there. We are doing what we can to provide support in all forms to African countries and are very pleased to be a co-organizer of this meeting. Only through solidarity and cooperation can we win this fight! "

"As by 27 April, there were 299 COVID-19 confirmed cases in Tanzania. We are striving to control the spread of the epidemic by strengthening various case management measures." Dr Leonard M. Subi, Directorate. of Preventive Services of Tanzanian Ministry of Health introduced the COVID-19 situation in Tanzania and the prevention strategy in Tanzania and said that more knowledge of prevention and protection is needed in practice.

Professor Lu Hongzhou, CPC Committee Secretary of Shanghai Public Health Clinical Centre, is a member of the China Medical Treatment Expert Group for COVID-19 and a support team member of China's overseas anti-epidemic medical expert group. He joined a China medical aid team to West Africa in 2014 to engage in the local fight against the Ebola epidemic.

For several consecutive months, Prof. Lu Hongzhou has been saving patients while conducting considerable clinical researches. In his lecture, Prof. Lu gave a systematic review on COVID-19 research updates from the aetiology, virology, pathology and therapeutic angles of the disease, and shared Shanghai's prevention and treatment experiences. "Shanghai's high cure rate of COVID-19 could not have been possible without great experience of its expert group members, advanced equipment, and most importantly, a strong medical team composed of experts from many domestic general hospitals," said Dr. Lu. Besides, the percentage of critically ill cases in Shanghai has remained low compared to many other Chinese regions due to the timely and effective early warning and intervention mechanism. The expert group will work out a specific diagnosis and treatment plan after consultation for every severe and critical patient.

Nearly 400 healthcare professionals from Africa joined the meeting. The scientists and experts thought highly of the address of Prof. Lu Hongzhou and many African doctors proactively left messages and gave feedback online, hoping Professor Lu to share more with them.

Prof. Marcus Schultz, a consultant critical care physician at the Department of Intensive Care of Academic Medical Centre Amsterdam, is currently in the front line of the battle against COVID-19 in Europe. Prof. Schultz shared Europe's experiences in the management of severe COVID-19 patients and offered treatment advice for low- and middle income countries. One of his statements was that patients with COVID-19 can have very low oxygen saturations in their blood without this causing much distress. These patients can most of the time be treated with just supplemental oxygen, and can benefit from being nursed on their front. They often don't need mechanical ventilation.  "We see that the whole world is rushing to buy ventilators. The availability of sufficient oxygen, the right tubing and non-rebreathing masks to provide supplemental oxygen is at least as important, especially for regions with limited resources."

The speakers also stressed the importance of setting up a "Fortification against hospital-acquired infections". Prof. Jia Xiaomin, Chief Physician of Department of Respiratory Medicine of the Second Affiliated Hospital of Xuzhou Medical University, shared the experiences of Wuhan Jihe Hospital, a "zero hospital-acquired infection" example, in prevention and control of in-hospital infections and protecting its medical staff. He emphasised the importance of strictly complying with hospital-acquired management standards and applying adequate protection. Professor Jia led a medical aid team from Fosun Healthcare Group to Wuhan, Hubei Province shortly after the outbreak of the epidemic. After over three months' round-the-clock efforts of the team, Wuhan Jihe Hospital cured and discharged 515 patients, and had no death and no medical workers being infected.

That evening, Professor Arjen Dondorp, Deputy Director of the Mahidol-Oxford Tropical Medicine Research Unit in Thailand and a world recognized malaria scientist, commented on speakers' remarks. He said, "It is very important for countries around the world to unite in the fight against COVID-19. Exchange of experiences is crucial. Countries where the pandemic has just started to hit, like in Africa, can learn from countries that have already experienced the wave of COVID-19 patients overwhelming their health systems. Moreover, in Sub-Saharan African countries it is important that other important diseases such as malaria, can still be managed properly when the COVID-19 pandemic arrives. Sufficient testing capacity for both diseases will be important to ensure. "

On 25 April, World Malaria Day 2020, Fosun Pharma joined forces with its Africa business unit Tridem Pharma to donate through Shanghai Fosun Foundation around USD200,000 worth of anti-epidemic materials to eight African countries through their Ministry of Health, including Côte d'Ivoire, Mali, Burkina Faso, Democratic Republic of the Congo, Nigeria, Kenya, Tanzania and Uganda. The materials are intended to be used by front-line healthcare workers in these countries to protect themselves. Fosun Pharma hopes that these materials will help alleviate the burden on local health systems, facilitating the countries to reach their malaria prevention and control targets.

SOURCE Fosun Pharma

Modal title

Also from this source

World Malaria Day: Fosun Pharma's Self-Developed Artemisinin...

World Malaria Day: Fosun Pharma's Self-Developed Artemisinin...


Fosun Diagnostics Receives China NMPA Approval for Its...

Fosun Diagnostics Receives China NMPA Approval for Its...

Explore

More news releases in similar topics

  • Infection Control
  • Health Care & Hospitals
  • Pharmaceuticals
  • Medical Pharmaceuticals
  • Public Safety

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.